Lonza Group LONN.S said on Monday that China’s Junshi Biosciences 1877.HK has licensed the Swiss contract drug manufac …
( read original story …)
Home TECHNOLOGY Lonza licenses technology to China’s Junshi for experimental COVID-19 drug
ADVERTISEMENT
Categories
Beijing
22°
overcast clouds
humidity: 21%
wind: 1m/s SW
H 22 • L 20
Weather from OpenWeatherMap
Recent Posts
- Blinken to meet businesses in Shanghai as he kicks off a tough China trip 25/04/2024
- Geely-backed luxury EV brand Zeekr says it’s already beating Tesla in parts of China 25/04/2024
- China’s central bank drops hints at future bond trades, answering calls for muscular monetary action 25/04/2024
- US court sentences Chinese citizen to prison for threatening person who promoted democracy in China 25/04/2024
- China drives both EV production and sales—but the fate of the country’s EV brands could soon be in the hands of emerging markets like Thailand 25/04/2024
- Report: Tension Between Beijing and Washington Represents Major Roadblock for U.S. Companies in China 25/04/2024
- China prepares to send 3 astronauts to Tiangong space station as part of new program and moon exploration 25/04/2024
- Congress Passes Ukraine Bill With Support for Taiwan—China’s Response 25/04/2024
- Bahrain’s Investcorp teams up with China to invest $1bn in Gulf and Asia 25/04/2024
- China’s Temu Takes Over 17% Of US Market Share, Cutting Jobs From American Amazon And Decimating Small Businesses 25/04/2024
- GRAPHIC: China returns as one of top poultry export destinations 25/04/2024
- Shenzhen’s Inbound Tourism Market Thrives, Accommodation Industry Seizes New Opportunities 25/04/2024